sc 58125 has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Ni, K; Peng, Y; Zang, T; Zhou, L; Zhou, X | 1 |
| Graham, SH; Hickey, RW; Li, W; Liu, H; Miller, TM; Pickrell, AM; Poloyac, SM; Rose, ME; Shinde, SN | 1 |
| Chen, JD; Chinkes, D; Chung, DH; Espana-Tenorio, J; Herndon, DN; Oliveira, HM; Sallam, HS | 1 |
| Brunette, E; Gendron, TF; Mealing, GA; Morley, P; Nguyen, A; Tauskela, JS | 1 |
| Graham, SH; Rose, ME; Wu Chen, R; Zhang, Y | 1 |
| Chen, J; Graham, SH; Hickey, RW; Kawaguchi, K; Rose, ME; Zhu, L | 1 |
| Dixon, CE; Graham, SH; Marion, DW; Resnick, DK | 1 |
| Chapman, K; McKnight, W; Wallace, JL | 1 |
| Conway, CM; Dirig, DM; Isakson, PC; Luo, ZD; Svensson, C; Yaksh, TL | 1 |
10 other study(ies) available for sc 58125 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
COX-2 contributed to the remifentanil-induced hyperalgesia related to ephrinB/EphB signaling.
Topics: Animals; Cyclooxygenase 2; Disease Models, Animal; Ephrins; Hyperalgesia; Injections, Spinal; Mice; Pyrazoles; Receptors, N-Methyl-D-Aspartate; Remifentanil; Spinal Cord | 2019 |
COX2-derived primary and cyclopentenone prostaglandins are increased after asphyxial cardiac arrest.
Topics: Animals; Animals, Newborn; Asphyxia; Brain Ischemia; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Heart Arrest; Hippocampus; In Situ Nick-End Labeling; Male; Mass Spectrometry; Prostaglandins; Pyrazoles; Rats; Rats, Sprague-Dawley; Resuscitation | 2013 |
Gastric and small bowel ileus after severe burn in rats: the effect of cyclooxygenase-2 inhibitors.
Topics: Animals; Burns; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Gastric Emptying; Gastrointestinal Transit; Ileus; Intestine, Small; Male; Phenolsulfonphthalein; Pyrazoles; Rats; Rats, Sprague-Dawley | 2009 |
Opposing effects of cyclooxygenase-2 selective inhibitors on oxygen-glucose deprivation-induced neurotoxicity.
Topics: Animals; Calcium; Canada; Cell Death; Cells, Cultured; Cerebral Cortex; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytosol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Induction; Extracellular Space; Glucose Metabolism Disorders; Glutamates; Hypoxia; Mice; Mice, Inbred C57BL; Neurotoxicity Syndromes; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sulfonamides; Time Factors | 2004 |
Cyclooxygenase-2 activity contributes to neuronal expression of cyclin D1 after anoxia/ischemia in vitro and in vivo.
Topics: Animals; Cell Survival; Cells, Cultured; Cyclin D1; Cyclooxygenase 2; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Hypoxia-Ischemia, Brain; Infarction, Middle Cerebral Artery; Neurons; Neuroprotective Agents; Nitrobenzenes; Piperidines; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2004 |
Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus.
Topics: Animals; Cell Death; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Epilepsy; Excitatory Amino Acid Agonists; Gene Expression Regulation, Enzymologic; Hippocampus; Kainic Acid; Male; Neurons; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley | 2005 |
Role of cyclooxygenase 2 in acute spinal cord injury.
Topics: Acute Disease; Animals; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Immunohistochemistry; In Situ Hybridization; Isoenzymes; Male; Peroxidases; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Long-Evans; RNA, Messenger; Spinal Cord; Spinal Cord Injuries; Treatment Outcome | 1998 |
Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Interactions; Indomethacin; Inflammation; Isoenzymes; Leukocytes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Thiophenes | 1999 |
The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Ibuprofen; Injections, Intraperitoneal; Injections, Spinal; Isoenzymes; Male; Membrane Proteins; N-Methylaspartate; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 2001 |